Hepion Pharmaceuticals, Inc.·4

Feb 18, 4:05 PM ET

Foster Robert T 4

4 · Hepion Pharmaceuticals, Inc. · Filed Feb 18, 2021

Insider Transaction Report

Form 4
Period: 2021-02-18
Foster Robert T
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2021-02-18$2.00/sh+20,000$40,00045,259 total

Documents

1 file
  • 4
    tm217063-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT